Early Use of Higher-Efficacy Therapies Recommended for Moderate

WEDNESDAY, Nov. 26, 2025 (HealthDay News) -- Early use of higher-efficacy therapies is recommended for patients with moderately to severely active Crohn disease

See Full Page

Interests (0)

Settings

Early Use of Higher-Efficacy Therapies Recommended for Moderate

ABC Correspondent Becomes Stem Cell Donor to Help Patient

'Another terrible decision': RFK Jr. stuns analysts with latest 'head

Republicans balk at Trump’s health care proposal before it’s even released

More people are addicted to marijuana but fewer of them are seek help, experts say

Health care plan circulated by the White House runs into familiar GOP divisions

The cancer blood test making waves – and what the numbers really show

Trump-era global funding cuts devastate HIV prevention programmes, UNAIDS says

After heartbreaking loss, one family advocates for flu vaccination

'Find the votes': Trump threatens to primary Republicans who don't support election scheme

Trump, 79, Feuds With His White House Ballroom Architect Over Bonkers Demand

First-Trimester Ultrasounds Detect 40 Percent of Anomalies

Grant Funding Disruptions Affect One in 30 Clinical Trials

Adenotonsillectomy Safe in Children With Down Syndrome, Other Genetic Syndromes

FBI and DOJ Review Epstein Files for Public Release

Thanksgiving winter storm warning as 30 inches of snow to strike

Ukrainian President Volodymyr Zelensky Responds to Doanld Trump’s Tantrum About Gratitude

Amazon Issues Account Attackers Warning to 300 Million

Five Dead, Including Three Children, in Douglas County Crash

Judge Dismisses Charges Against James Comey and Letitia James

These retailers are closed for Thanksgiving 2025: How early they open for Black Friday

Dad Has Sweet Reaction After Daughter Gives Herself an Extreme Haircut (Exclusive)

DC Mayor Bowser announces she won’t seek fourth term, as Trump’s federal intervention continues

Gas Prices Near Four-Year Low Ahead of Thanksgiving Travel